Beta Bionics (BBNX) Change in Accured Expenses (2024 - 2026)

Beta Bionics has disclosed Change in Accured Expenses across 3 years of filings, most recently posting -$5.2 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$5.2 million, up 1.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (up 316.48% YoY), and the FY2025 annual result was $7.4 million, up 8.57% from the prior year.
• Change in Accured Expenses came in at -$5.2 million for Q1 2026 at Beta Bionics, down from $5.9 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.9 million in Q4 2025 to a low of -$5.3 million in Q1 2025.
• The 3-year median for Change in Accured Expenses is $2.3 million (2024), against an average of $1.0 million.
• Peak annual rise in Change in Accured Expenses reached 242.92% in 2025, while the deepest fall reached 2182.68% in 2025.
• Beta Bionics' Change in Accured Expenses stood at $3.6 million in 2024, then jumped by 64.16% to $5.9 million in 2025, then plunged by 189.04% to -$5.2 million in 2026.
• The last three Change in Accured Expenses figures came in at -$5.2 million (Q1 2026), $5.9 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.